Back
Helmerich & Payne Vs. Ultragenyx Pharmaceutical Industry Stock Comparison
Sell
30
HP
Helmerich & Payne
Last Price:
38.31
Seasonality Move:
0.14%
Sell
47
RARE
Ultragenyx Pharmaceutical
Last Price:
42.55
Seasonality Move:
12.29%
Sell
30
Helmerich & Payne (HP)
is a Sell
Is Helmerich & Payne a Buy, Sell or Hold?
- The current Helmerich & Payne [HP] share price is $38.21. The Score for HP is 30, which is 40% below its historic median score of 50, and infers higher risk than normal.
- HP is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
47
Ultragenyx Pharmaceutical (RARE)
is a Sell
Is Ultragenyx Pharmaceutical a Buy, Sell or Hold?
- The current Ultragenyx Pharmaceutical [RARE] share price is $42.61. The Score for RARE is 47, which is 6% below its historic median score of 50, and infers higher risk than normal.
- RARE is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
HP Stock Price Chart
What is Helmerich & Payne's stock price today?
-
The Helmerich & Payne share price today is $38.21
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and HP is experiencing slight buying pressure.
RARE Stock Price Chart
What is Ultragenyx Pharmaceutical's stock price today?
-
The Ultragenyx Pharmaceutical share price today is $42.61
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and RARE is experiencing buying pressure, which is a positive indicator for future bullish movement.
HP Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.71 | Sell |
Relative Strength Index (14 RSI): | 38.51 | Sell |
Chaikin Money Flow: | 412677 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (38.44 - 41.4) | Sell |
Bollinger Bands (100): | (36.03 - 41.49) | Sell |
RARE Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -1.23 | Sell |
Relative Strength Index (14 RSI): | 45.9 | Sell |
Chaikin Money Flow: | 672942 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (41.5 - 44.36) | Sell |
Bollinger Bands (100): | (43.26 - 49.38) | Sell |
HP Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 38.69 | Sell |
20-day SMA: | 39.57 | Sell |
50-day SMA: | 40.74 | Sell |
200-day SMA: | 39.62 | Sell |
8-day EMA: | 38.7 | Sell |
20-day EMA: | 39.4 | Sell |
50-day EMA: | 39.86 | Sell |
200-day EMA: | 39.36 | Sell |
RARE Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 41.41 | Buy |
20-day SMA: | 42.68 | Sell |
50-day SMA: | 45.44 | Sell |
200-day SMA: | 42.06 | Buy |
8-day EMA: | 41.75 | Buy |
20-day EMA: | 42.77 | Sell |
50-day EMA: | 44.51 | Sell |
200-day EMA: | 44.25 | Sell |
Helmerich & Payne Earnings Growth & HP Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.08 per share, an increase next quarter of $0.12 per share, a decrease this year of $0.74 per share, and an increase next year of $0.35 per share.
Ultragenyx Pharmaceutical Earnings Growth & RARE Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.46 per share, an increase next quarter of $0.08 per share, an increase this year of $0.87 per share, and an increase next year of $1.24 per share.
Helmerich & Payne Technical Analysis
May 3 | May 6 | May 7 | May 8 | May 9 | May 10 | May 13 | May 14 | May 15 | May 16 | |
---|---|---|---|---|---|---|---|---|---|---|
May | ||||||||||
03 | 06 | 07 | 08 | 09 | 10 | 13 | 14 | 15 | 16 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Ultragenyx Pharmaceutical Technical Analysis
May 3 | May 6 | May 7 | May 8 | May 9 | May 10 | May 13 | May 14 | May 15 | May 16 | |
---|---|---|---|---|---|---|---|---|---|---|
May | ||||||||||
03 | 06 | 07 | 08 | 09 | 10 | 13 | 14 | 15 | 16 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |